Department of Health and Social Care written question – answered on 27 November 2018.

Alert me about debates like this

Photo of Ranil Jayawardena Ranil Jayawardena Conservative, North East Hampshire

To ask the Secretary of State for Health and Social Care, what progress he has made on the acquisition of Orkambi for the NHS.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.

Does this answer the above question?

Yes3 people think so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.